Additionally, it is important to note that our analysis is based on bulk NGS and not on single-cell analysis and, secondly, that NPM1m AML cases may harbor two or more NPM1-mutated subclones with different mutational profiles (and correspondingly possibly different immunophenotypic profiles), which may complicate categorization. This evidence concerns the gene NPM1 and acute myeloid leukemia.